Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation

Key facts

Sponsor

University of Turin, Italy

Intervention

Sample collation for cfDNA methylation analysis(diagnostic_test)

Enrollment

30 target

Eligibility

18 years · All sexes

Timeline

2024 – 2026

Study locations (2)

• Unità di Ematologia e Trapianto di Midollo Osseo e Oncoematologia of the San Raffaele Hospital in Milan, Milan, Milan, Italy
• SS Trapianto allogenico e terapie cellulari, SC Ematologia U of the Città della Salute e della Scienza Hospital, Turin, Turin, Italy

Collaborators

IRCCS San Raffaele

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Hepatic veno-occlusive disease

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT05987124
  Defibrotide Dose-escalation for SOS Post-HSCT
  New York Medical College
• RECRUITINGNCT05090345
  A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).
  Duke University
• ACTIVE NOT RECRUITINGNANCT03865589
  Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
  Children's Mercy Hospital Kansas City

See all trials for Hepatic veno-occlusive disease →